Skip to main content
Tuesday, November 10, 2026Nov 10

Medical trials affirm Erlanger’s place at ‘forefront of stroke treatment’

Erlanger Hospital is seen from the UTC library's balcony in this Dec. 9, 2014, file photo.
Erlanger Hospital is seen from the UTC library's balcony in this Dec. 9, 2014, file photo. Erlanger Hospital is seen from the UTC library's balcony in this Dec. 9, 2014, file photo.
photo Dr. Blaise Baxter

Stroke doctors at Erlanger Health System were all smiles as they stood before their colleagues in a conference room on Tuesday.

“As you can see, we’re in a very celebratory mood,” said Dr. Blaise Baxter, chief neurointerventional radiologist at the hospital. “This is a historic day, and it represents the culmination of work we’ve done since 1999.”

Historic is a word “we don’t use lightly,” said Dr. Tom Devlin, chairman of Erlanger’s neurosciences department.

The hospital is heralding its role in a breakthrough in acute stroke treatment, as a series of successful clinical trials will soon “usher in a new era for stroke treatment,” Devlin said.

The treatment, known as endoscopy, uses tiny devices threaded through a stroke victim’s blood vessels to fish out blood clots in the brain. At Erlanger, the method has been a standard part of treating the most severe strokes since the late 1990s.